Real-life dosing with second-generation antipsychotics. [electronic resource]
- The Journal of clinical psychiatry Dec 2005
- 1610-1 p. digital
Publication Type: Journal Article
0160-6689
10.4088/jcp.v66n1218 doi
Antipsychotic Agents--administration & dosage Clinical Trials, Phase IV as Topic Drug Administration Schedule Drug Approval Humans Maximum Tolerated Dose Product Surveillance, Postmarketing Psychotic Disorders--drug therapy Randomized Controlled Trials as Topic Schizophrenia--drug therapy Schizophrenic Psychology Treatment Outcome United States United States Food and Drug Administration